ATWLPPR Peptide

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

ATWLPPR Peptide TFA

CAS No. :

MCE 国际站：ATWLPPR Peptide TFA

产品活性：ATWLPPR Peptide TFA 是一种选择性的 neuropilin-1 (NRP-1) 抑制剂，能够抑制 VEGF₁₆₅ 与 NRP-1 结合，可用于血管生成的研究。ATWLPPR Peptide TFA 能够减轻糖尿病引起的早期视网膜损伤。

研究领域：Immunology/Inflammation

作用靶点：Complement System

In Vitro: ATWLPPR Peptide TFA is a selective neuropilin-1 inhibitor, inhibits VEGF₁₆₅ binding to NRP-1 by 82% at 100 μM.

In Vivo: ATWLPPR (400 μg/kg, s.c.) preserves vascular integrity and decreases the oxidative stress level, possibly reduces the early retinal damage caused by diabetes.
ATWLPPR prevents the increase of inflammation-associated proteins (GFAP, VEGF and ICAM-1) in the retina.

相关产品：Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Anti-Aging Compound Library  |  Anti-diabetic Compound Library  |  Oxygen Sensing Compound Library  |  Anti-Cardiovascular Disease Compound Library  |  Anti-Obesity Compound Library  |  Heterocyclic Compound Library  |  Membrane Protein-targeted Compound Library  |  Autoimmune Disease Compound Library  |  Highly Selective Inhibitors Library  |  Dexamethasone  |  Cyclosporin A  |  SB290157 trifluoroacetate  |  EG00229  |  Iptacopan  |  PMX-53  |  Danicopan  |  JR14a  |  PMX 205 Trifluoroacetate  |  EG01377 dihydrochloride  |  Compstatin  |  AMY-101 acetate  |  Leukadherin-1  |  W-54011  |  JPE-1375  |  Eculizumab  |  TLQP-21 TFA  |  Vesencumab  |  Vemircopan  |  Avacincaptad pegol sodium  |  POT-4  |  BCX 1470 methanesulfonate  |  Complement C5-IN-1  |  C3a receptor agonist 1  |  FD-IN-1  |  Sutimlimab

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds